Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Mohawk’s Medella Series Redefines Resilient Flooring

In a significant development, Mohawk Group has secured the exclusive distribution rights for the highly sought-after homogeneous resilient sheet products in North America. These popular products, formerly distributed by another company, are now proudly part of Mohawk’s Healthy Environments collection, specifically named Medella, Medella Hues, Medella Sheet, and Medella Well. One standout product in this…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Mohawk Group on MarketScale.

Share

In a significant development, Mohawk Group has secured the exclusive distribution rights for the highly sought-after homogeneous resilient sheet products in North America. These popular products, formerly distributed by another company, are now proudly part of Mohawk’s Healthy Environments collection, specifically named Medella, Medella Hues, Medella Sheet, and Medella Well.

One standout product in this collection is Medella Well, an exceptional PBC-free sheet product that excels in performance and versatility, making it ideal for a wide range of applications. With its superior qualities, Medella Well has become a standard choice in medical facilities throughout North America, catering to the specific needs of the healthcare industry.

As sustainability continues to gain importance in the architectural and design community, environmental performance has become a crucial consideration for specifiers and end-users in the AMD industry. Recognizing this trend, Mohawk Group remains dedicated to leading the flooring industry, as well as the broader manufacturing sector, in environmental responsibility.

This exclusive distribution agreement not only reinforces Mohawk Group’s commitment to providing high-quality, sustainable flooring solutions but also positions them as a frontrunner in meeting the evolving demands of the market. By offering top-selling resilient sheet products under the Healthy Environments collection, Mohawk Group demonstrates their unwavering dedication to creating healthier, greener, and more sustainable spaces for all.

Video TranscriptExpand ↓

Last September, Moach group became exclusive supplier of the top selling homogeneous resilient sheet products in North America. Previously distributed by another company, these four style are now called Modela, Modela Hughes, Modela Flex, and Modela Well, under our healthy environments collection. Modela well is a great solution if you're needing a high performing PBC free sheet product. These are the same products that are standardized in hundreds of medical facilities throughout North America. Environmental performance continues to be highly influential with AMD specifiers and large end users. And we are committed to leading not only the floor industry, but the entire manufacturing sector as well.

Mohawk Group

Part of this channel

Mohawk Group

Commercial flooring built on sustainability, design, and people-first thinking.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512